Progress towards rabies control.
Although safe and efficacious tissue-culture-derived rabies vaccines are available in developed countries, much of the world still depends on vaccines derived from neural tissue which were introduced half a century ago. Considerable advances have been made in our understanding of the molecular biology of rabies virus, and genetically engineered recombinant viruses (vaccinia-rabies virus glycoprotein) have been developed. These may facilitate the control of rabies in some species by oral vaccination campaigns.
Division of Virology, National Institute for Biological Standards and Control, Potters Bar, Herts, UK.
M
M
Ferguson
D000818:Animals; D004333:Drug Administration Routes; D006801:Humans; D007114:Immunization; D011818:Rabies / Q000517:prevention & control*; D011819:Rabies Vaccines / Q000008:administration & dosage; D011820:Rabies virus / Q000648:ultrastructure; D014611:Vaccination; D014614:Vaccines, Synthetic / Q000008:administration & dosage
D011819:Rabies Vaccines; D014614:Vaccines, Synthetic